Vir Biotechnology
(NASDAQ) VIR
Vir Biotechnology Financials at a Glance
Market Cap
$1.45B
Revenue (TTM)
$68.56M
Net Income (TTM)
$437.99M
EPS (TTM)
$-3.16
P/E Ratio
-2.86
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$9.04
Volume
63,465
Open
$8.72
Price
$9.04
Volume
63,465
Open
$8.72
Previous Close
$9.04
Daily Range
$8.72 - $9.39
52-Week Range
$4.16 - $10.94
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$9.04
Volume
63,465
Open
$8.72
Previous Close
$9.04
Daily Range
$8.72 - $9.39
52-Week Range
$4.16 - $10.94
VIR News
VIR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vir Biotechnology
Industry
Biotechnology
Sector
Health CareEmployees
367
CEO
Marianne de Backer, PhD, MBA
Website
www.vir.bioHeadquarters
San Francisco, CA 94158, US
VIR Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-7%
Net Income Margin
-6%
Return on Equity
-46%
Return on Capital
-51%
Return on Assets
-44%
Earnings Yield
-34.97%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.45B
Shares Outstanding
159.81M
Volume
63.47K
Short Interest
0.00%
Avg. Volume
3.55M
Financials (TTM)
Gross Profit
$56.85M
Operating Income
$468.02M
EBITDA
$426.09M
Operating Cash Flow
$391.78M
Capital Expenditure
$4.83M
Free Cash Flow
$396.61M
Cash & ST Invst.
$462.86M
Total Debt
$186.91M
Vir Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$64.07M
+417.8%
Gross Profit
$430.63M
+663.5%
Gross Margin
6.72%
N/A
Market Cap
$1.45B
N/A
Market Cap/Employee
$3.55M
N/A
Employees
408
N/A
Net Income
$42.92M
+59.0%
EBITDA
$40.16M
+59.9%
Quarterly Fundamentals
Net Cash
$275.95M
-65.8%
Accounts Receivable
$3.60M
-29.4%
Inventory
$0.00
N/A
Long Term Debt
$178.11M
+97.6%
Short Term Debt
$8.80M
+13.5%
Return on Assets
-43.68%
N/A
Return on Invested Capital
-51.43%
N/A
Free Cash Flow
$21.39M
+76.2%
Operating Cash Flow
$25.88M
+70.5%